Global Price Control Elimination May Not Affect U.S. Rx Costs, Economist Tells ITA Panel
This article was originally published in The Pink Sheet Daily
Executive Summary
Payoff from elimination of price controls would be enhanced innovation, not lower costs in U.S., panelists tell Commerce Department hearing. International Rx pricing study is due Sept. 8.